A Trial of Selinexor, Ruxolitinib and Methylprednisolone

Conditions: Multiple Myeloma in Relapse; Multiple Myeloma, Refractory Interventions: Drug: Selinexor; Drug: Ruxolitinib; Drug: Methylprednisolone Sponsors: Oncotherapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials